|
NEWSNOTES
SCIENCE NEWS
No
Joke: What's in a laugh? Much more than scientists expected, apparently.
As many as 1,024 laughter episodes from 97 adults watching funny videos
like Monty Python were analysed and reported in the Journal of the Acoustical
Society of America. Psychologists discovered that men tend to grunt and
snort more often while women are more likely to produce "song-like
laughter" using the vocal fold in the larynx. Sounds of laughter
are generally higher pitched than a person's normal voice-the frequencies
match those of the high 'C' of the soprano singer. And whirlpools of air
near the larynx could cause the distinctive "nervous" laugh.
Attractiveness
Effect: Ever been told that you light up the room you enter? It really
happens-if you're good-looking, that is. Nature reports that when a person
sees an attractive face, a region of the brain called the ventral striatum
lights up. Unattractive faces have no effect. The same region is activated
in drug addicts and gamblers when they are about to indulge in their habit.
Scientists came to this conclusion after scanning the brains of eight
men and eight women while they looked at 160 photos of faces and rated
them on attractiveness.
Jet-setting
Particles: The dust on your table could be an inter-continental traveller.
Studies by the US Geological Survey have shown that dust travels widely
and has an impact far away from its origin. Dust particles from the Sahara
desert in Africa, for example, have been found to pollute Miami, Florida,
by forming half the breathable particles in the city (100 micrograms per
cubic metre are African particles). Emerging data also show that dirt
from one continent could contribute to agricultural losses and human disease
in another as bacteria and fungi ride with the dust.
DRUG ALERT
Attacking
Arthritis: Arava, India's first oral medicine specifically designed
against rheumatoid arthritis, was launched to mark World Arthritis Day
on October 12. Rheumatoid arthritis is an auto-immune disease that affects
10 million Indians, according to the Indian Rheumatology Association.
More prevalent in women, the disease damages the joints and is also known
to shorten lifespan.
Pigs With Wings: Xenotransplantation,
the transplanting of an organ from one species to another, came a step
closer to reality with the birth of a litter of pigs in the US. These
pigs carry selected genetic traits of jellyfish. Eventually it should
be possible to change the genetic make-up of cells to grow organs that
can be used for humans.
The
Unisex Pill: The ultimate contraceptive pill-one equally effective
in men and women-is almost within sight. Scientists at Harvard Medical
School have found that sperm starved of calcium are too weak to break
into an egg. So a drug that temporarily blocks calcium, and functions
locally, may be the key to cheap, effective contraception.
HEALTH
CANCER
Relief From Painful Jabs
Cancer
victims are unfairly hit with a double whammy-harsh, long-drawn chemotherapy
causes almost as much suffering as the disease itself. That could now
be avoided through ports, a new technology for delivering drugs that is
increasingly being used in India.
During chemotherapy, the patient is frequently
injected with drugs over a period stretching from several weeks to several
months. Repeated jabbing of the arms causes pain, swelling, increases
risk of infection, and sometimes makes the vein difficult to find. port
provides an alternative. It is a titanium-and-plastic device placed surgically
below the skin in the chest and connected to the blood supply. It has
a chamber that can hold the drug, which is then delivered to the body
at regular intervals. The device costs between Rs 4,000 and Rs 14,000,
and depending on its quality, can last from a year to a lifetime. It is
designed not to cause any immunological reaction within the body. "The
risk is no greater than that of any minor surgery," says Sameer Kaul,
senior consultant surgical oncologist at Delhi's Indraprashtha Apollo
Hospital. Kaul has implanted the device in more than 200 patients.
"With ports, one can undergo chemotherapy
and still go to work regularly, and even travel," says Kaul. In Europe,
although 80 per cent of users are cancer patients, the device also helps
thalassemics, who require frequent blood transfusion, and those who need
long-term intravenous nourishment. port allows patients the hope of leading
a normal life.
Supriya Bezbaruah
|